CATALYST PHARMACEUTICALS INC. - COMMON STOCK
21.48
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.36
+1.70%
Today's range
21.05 - 21.55
ISIN
N/A
Source
NASDAQ
-
Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®
23 Jan 2023 07:03:00 By Nasdaq GlobeNewswire
-
19 Dec 2022 15:10:00 By Nasdaq GlobeNewswire
-
09 Nov 2022 15:11:31 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year
07 Nov 2022 07:03:37 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
25 Oct 2022 07:03:00 By Nasdaq GlobeNewswire
-
29 Sep 2022 10:18:17 By Nasdaq GlobeNewswire
-
09 Sep 2022 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals To Participate in Citi's 17th Annual BioPharma Conference
24 Aug 2022 07:03:00 By Nasdaq GlobeNewswire
-
09 Aug 2022 15:26:30 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022
26 Jul 2022 07:03:00 By Nasdaq GlobeNewswire
-
12 Jul 2022 05:00:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
17 May 2022 07:03:00 By Nasdaq GlobeNewswire
-
10 May 2022 15:11:56 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Report First Quarter 2022 Financial Results on May 10, 2022
25 Apr 2022 07:03:00 By Nasdaq GlobeNewswire
-
16 Mar 2022 15:20:58 By Nasdaq GlobeNewswire
-
11 Mar 2022 07:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Named Among Forbes 2022 America's Best Small Companies
08 Mar 2022 07:03:00 By Nasdaq GlobeNewswire
-
03 Mar 2022 08:20:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Further Strengthens FIRDAPSE® U.S. Patent Portfolio
02 Mar 2022 07:03:00 By Nasdaq GlobeNewswire
-
24 Feb 2022 07:03:00 By Nasdaq GlobeNewswire